Cargando…
Research in haematological cancers: What do patients in the Netherlands prioritise?
INTRODUCTION: The experiential knowledge of patients can provide research communities with complementary perspectives on disease. The aim of this study was to identify and prioritise everyday problems and research needs of haematological cancer patients and people who have undergone a stem cell tran...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285610/ https://www.ncbi.nlm.nih.gov/pubmed/30675743 http://dx.doi.org/10.1111/ecc.12989 |
_version_ | 1784747823870246912 |
---|---|
author | Schölvinck, Anne‐Floor M. de Graaff, Bert M. B. van den Beld, Mechteld J. Broerse, Jacqueline E. W. |
author_facet | Schölvinck, Anne‐Floor M. de Graaff, Bert M. B. van den Beld, Mechteld J. Broerse, Jacqueline E. W. |
author_sort | Schölvinck, Anne‐Floor M. |
collection | PubMed |
description | INTRODUCTION: The experiential knowledge of patients can provide research communities with complementary perspectives on disease. The aim of this study was to identify and prioritise everyday problems and research needs of haematological cancer patients and people who have undergone a stem cell transplantation. METHODS: A mixed‐method participatory research approach (the Dialogue Model) was applied, including interviews (n = 19), four focus group discussions (n = 27), a questionnaire (n = 146) and a stakeholder dialogue meeting (n = 30) with patients in the Netherlands. RESULTS: Patients’ physical discomfort, psychosocial issues, problems with the healthcare system and policy issues were highlighted. Respondents prioritise research aimed at factors potentially influencing survival, such as lifestyle, and research aimed at improving patients’ quality of life, for example improving memory and concentration problems. Topics also focused on physical discomfort, causal mechanisms, and healthcare organisation and policies. Research of a social scientific character is underrepresented, and as such, patients’ everyday problems are not all directly reflected in the research agenda. CONCLUSIONS: Our findings indicate that patients, besides emphasising the importance of improving survival, have a clear desire to increase control over their lives. |
format | Online Article Text |
id | pubmed-9285610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92856102022-07-18 Research in haematological cancers: What do patients in the Netherlands prioritise? Schölvinck, Anne‐Floor M. de Graaff, Bert M. B. van den Beld, Mechteld J. Broerse, Jacqueline E. W. Eur J Cancer Care (Engl) Original Articles INTRODUCTION: The experiential knowledge of patients can provide research communities with complementary perspectives on disease. The aim of this study was to identify and prioritise everyday problems and research needs of haematological cancer patients and people who have undergone a stem cell transplantation. METHODS: A mixed‐method participatory research approach (the Dialogue Model) was applied, including interviews (n = 19), four focus group discussions (n = 27), a questionnaire (n = 146) and a stakeholder dialogue meeting (n = 30) with patients in the Netherlands. RESULTS: Patients’ physical discomfort, psychosocial issues, problems with the healthcare system and policy issues were highlighted. Respondents prioritise research aimed at factors potentially influencing survival, such as lifestyle, and research aimed at improving patients’ quality of life, for example improving memory and concentration problems. Topics also focused on physical discomfort, causal mechanisms, and healthcare organisation and policies. Research of a social scientific character is underrepresented, and as such, patients’ everyday problems are not all directly reflected in the research agenda. CONCLUSIONS: Our findings indicate that patients, besides emphasising the importance of improving survival, have a clear desire to increase control over their lives. John Wiley and Sons Inc. 2019-01-23 2019-03 /pmc/articles/PMC9285610/ /pubmed/30675743 http://dx.doi.org/10.1111/ecc.12989 Text en © 2019 The Authors. European Journal of Cancer Care Published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Schölvinck, Anne‐Floor M. de Graaff, Bert M. B. van den Beld, Mechteld J. Broerse, Jacqueline E. W. Research in haematological cancers: What do patients in the Netherlands prioritise? |
title | Research in haematological cancers: What do patients in the Netherlands prioritise? |
title_full | Research in haematological cancers: What do patients in the Netherlands prioritise? |
title_fullStr | Research in haematological cancers: What do patients in the Netherlands prioritise? |
title_full_unstemmed | Research in haematological cancers: What do patients in the Netherlands prioritise? |
title_short | Research in haematological cancers: What do patients in the Netherlands prioritise? |
title_sort | research in haematological cancers: what do patients in the netherlands prioritise? |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285610/ https://www.ncbi.nlm.nih.gov/pubmed/30675743 http://dx.doi.org/10.1111/ecc.12989 |
work_keys_str_mv | AT scholvinckannefloorm researchinhaematologicalcancerswhatdopatientsinthenetherlandsprioritise AT degraaffbertmb researchinhaematologicalcancerswhatdopatientsinthenetherlandsprioritise AT vandenbeldmechteldj researchinhaematologicalcancerswhatdopatientsinthenetherlandsprioritise AT broersejacquelineew researchinhaematologicalcancerswhatdopatientsinthenetherlandsprioritise |